Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.

about

Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.

Item

http://www.wikidata.org/entity/Q51821116

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.

@en

Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.

@nl

type

Item

label

Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.

@en

Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.

@nl

prefLabel

Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.

@en

Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.

@nl

P1476

Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.

@en

P2093

Akiko Iida-Klein

http://www.w3.org/2001/XMLSchema#string

M Zouhair Atassi

http://www.w3.org/2001/XMLSchema#string

Minako Oshima

http://www.w3.org/2001/XMLSchema#string

Philip R Deitiker

http://www.w3.org/2001/XMLSchema#string

Takahiro Maruta

http://www.w3.org/2001/XMLSchema#string

P2860

Bone versus immune system

Osteoimmunology: interplay between the immune system and bone metabolism

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

Osteoclast differentiation and activation

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

Medical baseline data collection on bone and muscle change with space flight.

Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.

Vaccination with a MHC class II peptide attenuates cellular and humoral responses against tAChR and suppresses clinical EAMG.

Unravelling the pathogenesis of myasthenia gravis.

IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation.

P304

346-353

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/08916934.2017.1367772

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28850269

http://www.w3.org/2001/XMLSchema#string

P921

myasthenia gravis